1. Signaling Pathways
  2. MAPK/ERK Pathway
  3. MAP3K

MAP3K 

MAP kinase kinase kinase, MEKK, MAPKKK

MAP3Ks (Mitogen-activated protein kinase kinase kinases), the top components of MAPK cascades, provide specificity for stimulus-dependent activation of MAP2K-MAPK pathways through unique protein-protein interactions and phosphorylation of signaling effectors. The MAP3Ks are highly divergent in gene numbers and structure, including TAK1, ASK1, A-Raf and C-Raf.

MAPK system is a three-step sequential phosphorylation cascade which is composed of MAPK, MAP2K, and MAP3K. ERK, p38 MAPK, and JNK, which are known to be activated by mechanical stimuli, belong to the MAPK family. MAP3Ks function as “platforms to integrate MAPK signaling, and activation of multiple MAP3Ks provides the spatiotemporal regulation of the MAPK pathways, which induces a wide range of physiological responses required for determining cell fate, such as cytokine production, survival, differentiation and apoptosis”.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-131969
    ASK1-IN-2 Inhibitor 99.55%
    ASK1-IN-2 是一种有效的,具有口服活性的凋亡信号调节激酶 1 (ASK1) 抑制剂,IC50 值为 32.8 nM。ASK1-IN-2 可用于溃疡性结肠炎的研究。
    ASK1-IN-2
  • HY-114331
    DLK-IN-1 Inhibitor 99.41%
    DLK-IN-1 是具有口服活性的双亮氨酸拉链激酶 (DLK, MAP3K12) 的选择性抑制剂,其Ki 值为 3 nM。DLK-IN-1 保持着良好的中枢神经系统穿透能力,并且在脑内剂量过量后依旧耐受性良好,在阿尔兹海默症动物模型中有良好的活性。
    DLK-IN-1
  • HY-114332
    GNE-8505 Inhibitor 99.86%
    GNE-8505 是一种口服有效的双亮氨酸拉链激酶 (DLK) 抑制剂。
    GNE-8505
  • HY-103258
    TC ASK 10 Inhibitor 99.84%
    TC ASK 10 (Compound 10) 是一种有效的,选择性的,口服活性的细胞凋亡信号调节激酶 1 (ASK1) 抑制剂,IC50 为 14 nM。TC ASK 10 对其他代表性激酶的抑制活性低于 50%,ASK2 除外 (IC50 为 0.51 μM)。
    TC ASK 10
  • HY-122642
    TAK1-IN-4 Inhibitor 99.47%
    TAK1-IN-4 (Compound 14) 是一种 TAK1 抑制剂。
    TAK1-IN-4
  • HY-15434A
    NG25 trihydrochloride Inhibitor
    NG25 trihydrochloride 是一种 TAK1MAP4K2 双重抑制剂 (IC50 分别为 149 nM 和 21.7 nM)。NG25 trihydrochloride 使乳腺癌细胞对 Doxorubicin (HY-15142A) 敏感,并增强细胞凋亡 (apoptosis)。NG25可用于多种癌症的研究。
    NG25 trihydrochloride
  • HY-122232
    SW083688 Inhibitor
    SW083688是一种强效、高选择性的 TAOK2 (Thousand-And-One Kinase 2)抑制剂 (IC50值= 1.3 umol/L)。
    SW083688
  • HY-146729
    ASK1-IN-3 Inhibitor
    ASK1-IN-3 是一种有效且具有选择性的 ASK1 激酶抑制剂,IC50 为 33.8 nM,同时也抑制多种细胞周期调节激酶。ASK1-IN-3 具有较强的 HepG2 癌细胞凋亡 (apoptosis) 诱导活性与有效的细胞周期阻滞活性。
    ASK1-IN-3
  • HY-152247
    DDO3711 Inhibitor
    DDO3711 是一种招募 PP5 的磷酸酶募集嵌合体 (PHORC),它是通过化学接头将小分子凋亡信号调节激酶 1 (ASK1) 抑制剂连接到 PP5 激活剂而形成的。DDO3711 特异性抑制 ASK1 (IC50 =164.1 nM) 不影响 ASK2 (IC50>20 μM)。DDO3711 通过募集 PP5 使 p-ASK1T838 显着去磷酸化,并显示 ASK1 依赖性抗增殖活性。DDO3711 有抗癌活性,具有用于异常磷酸化癌蛋白研究的潜力。
    DDO3711
  • HY-153320
    AZ-TAK1 Inhibitor
    AZ-TAK1 是 ATP竞争性的、TAK1 小分子抑制剂,在淋巴瘤细胞中使TAK1、p38 和IκB-α 去磷酸化。
    AZ-TAK1
  • HY-153761
    ASK1-IN-4 Inhibitor
    ASK1-IN-4 (Compound 17) 是一种 ASK1 抑制剂 (IC50=0.2 μM)。ASK1-IN-4 与 ASK1 的 ATP 结合位点相互作用。
    ASK1-IN-4
  • HY-155089
    IACS-52825 Inhibitor
    IACS-52825 是一种有效的选择性 DLK 抑制剂,其 Kd 值为1.3 nM,可用于研究化疗引起的周围神经病变。
    IACS-52825
  • HY-18297
    ASK1-IN-5 Inhibitor
    ASK1-IN-5 (S-99)是一种凋亡信号调节激酶 1 (ASK1) 抑制剂,可用于自身免疫性疾病和神经退行性疾病的研究。
    ASK1-IN-5
目录号 产品名 / 同用名 应用 反应物种

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.